首页 | 本学科首页   官方微博 | 高级检索  
     

慢性低O2高CO2大鼠血管内皮生长因子表达及参一胶囊的影响
引用本文:陈彦凡,陈少贤,范小芳,王良兴. 慢性低O2高CO2大鼠血管内皮生长因子表达及参一胶囊的影响[J]. 中国临床药理学与治疗学, 2004, 9(6): 709-712
作者姓名:陈彦凡  陈少贤  范小芳  王良兴
作者单位:温州医学院附属第一医院肺科,温州,325000,浙江
基金项目:浙江省教育厅基金 (№ 2 0 0 10 3 63 ),温州市科技局基金 (№S990 3 0 2C)资助课题
摘    要:目的 :探讨血管内皮生长因子 (VEGF)在低氧性肺动脉高压形成中的意义及参一胶囊对其影响。方法 :采用ELISA法、透射电镜、原位杂交技术等方法 ,观察正常对照组、低O2 高CO2 4周组、低O2 高CO2 4周 参一胶囊组大鼠肺动脉平均压 (mPAP)、右心室重量比 (RV LV S)、血清和肺组织的VEGF的含量、肺细小动脉的超微结构、肺组织VEGFmR NA表达的变化。结果 :低O2 高CO2 组大鼠的mPAP、RV LV S、血清和肺组织的VEGF的含量明显高于正常对照组 (P <0 .0 1)。低O2 高CO2 4周 参一胶囊组大鼠mPAP、RV LV S、血清VEGF显著低于低O2高CO2 组 (P <0 .0 1) ,肺组织的VEGF的含量也低于低O2 高CO2 组 (P <0 .0 5 )。低O2 高CO2 组大鼠肺细小动脉中膜平滑肌细胞明显增生、胶原纤维较正常对照组增多 ,低O2 高CO2 4周 参一胶囊组较低O2 高CO2 组则明显减轻。原位杂交显示低O2 高CO2 组大鼠肺细小动脉VEGFmRNA较正常对照组明显增加 (P <0 .0 1) ,而低O2 高CO2 4周 参一胶囊组与低O2 高CO2 组比较 ,则明显降低(P <0 .0 5 )。结论 :VEGF参与了慢性低氧性肺动脉高压的形成 ,参一胶囊可通过抑制VEGF的作用而有效地降低肺动脉高压

关 键 词:低氧  高二氧化碳  高血压  肺性  血管内皮生长因子  参一胶囊
文章编号:1009-2501(2004)06-0709-04
修稿时间:2004-01-31

Expression of vascular endothelial growth factor in chronic hypoxia and hypercapnia rats and effects of SHENYI Capsule
CHEN Yan-fan,CHEN Shao-Xian,FAN Xiao-Fang,WANG Liang-Xing. Expression of vascular endothelial growth factor in chronic hypoxia and hypercapnia rats and effects of SHENYI Capsule[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(6): 709-712
Authors:CHEN Yan-fan  CHEN Shao-Xian  FAN Xiao-Fang  WANG Liang-Xing
Affiliation:CHEN Yan-fan,CHEN Shao-Xian,FAN Xiao-Fang,WANG Liang-Xing Department of Lung,the First Affiliated Hospital,Wenzhou Medical College,Wenzhou 325000,Zhejiang,China
Abstract:AIM: To explore the roles of vascular endothelial growth factor (VEGF) in hypoxia pulmonary hypertension and effects of SHENYI Capsule. METHODS: Thirty SD rats were randomly divided into normal control group (N), hypoxia hypercapnia group (F), and hypoxia hypercapnia SHENYI Capsule group (S). The levels of VEGF in serum and lung tissue are measured by ELISA, the ultrastructure of pulmonary arterioles was observed by electron microscopy, and the expression of VEGFmRNA was observed by in situ hybirdization. RESULTS: Mean pulmonary arterial pressure (mPAP), weight ratio of RV to LV S, the levels of VEGF in serum, and lung tissue of group F were significantly higher than those of group N and group S (P< 0.01 or < 0.05). Electron microscopy showed proliferation of smooth muscle cells and collagenous fibers of pulmonary arterioles in rats of group F, and SHENYI Capsule could reverse the changes mentioned above. VEGF mRNA in pulmonary arterioles was significantly higher in rats of group F than that of group N(P<0.01), and it was significantly decreased in rats of group S than that of group F. CONCLUSION: VEGF plays an important role in the process of hypoxia pulmonary hypertension, and SHENYI Capsule can prevent hypoxia pulmonary hypertension by inhibiting the role of VEGF.
Keywords:hypoxia  hypercapnia  pulmonary hypertension  vascular endothelial growth factor  SHENYI Capsule
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号